Cathie Wood: portfolio of ARK Investment Management

Cathie Wood leads ARK Investment Management, which offers actively managed funds focused on technology and innovation.

Source: 13F filing with the US Securities and Exchange Commission dated Jan 17, 2024. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q4 2023. Go to the latest filing (Q3 2026)

16.9B USDQ4 2023
Total value of stock positions
16.9B USD
Positions
223
Share of the ten largest
48.7%

The ten largest positions Q4 2023

  1. Coinbase 8.9%▼ −18.9%
  2. UiPath Inc 6.4%▼ −8.1%
  3. Tesla, Inc. 5.6%▼ −6.8%
  4. Block, Inc. 5.4%▲ +9.2%
  5. Roku Inc 5.2%▼ −8.7%
  6. Zoom Video Communications Inc 4.7%▲ +7.7%
  7. Roblox 3.2%▼ −0.6%
  8. Twilio 3.2%▼ 0.0%
  9. CRISPR Therapeutics AG 3.2%▲ +19.2%
  10. Unity Software Inc 3.0%▲ +6.2%
Total value of stock positions per quarter, Q4 2016 to Q3 2026 (peak 53.7B USD).
Choose a quarter (40 filings)

All positions Q4 2023

Positions Q4 2023 per 13F filing, 50 of 94
Symbol Weight Shares Reported value Change Held since
XYZ Block, Inc. 5.4% 11,887,628 919.5M USD +9.2% increased Q4 2016 or earlier 29 quarters
Zoom Video Communications Inc 4.7% 10,964,576 788.5M USD +7.7% increased Q4 2020 13 quarters
CRISPR Therapeutics AG 3.2% 8,536,104 534.4M USD +19.2% increased Q2 2017 27 quarters
Unity Software Inc 3.0% 12,189,778 498.4M USD +6.2% increased Q3 2020 14 quarters
Teladoc Health Inc 2.7% 21,224,565 457.4M USD +4.5% increased Q3 2017 26 quarters
HOOD Robinhood Markets 2.6% 34,936,204 445.1M USD +6.4% increased Q3 2021 10 quarters
Intellia Therapeutics Inc 2.1% 11,412,449 348.0M USD +14.7% increased Q4 2016 or earlier 29 quarters
Pacific Biosciences of Califor 2.0% 34,504,273 338.5M USD +15.7% increased Q3 2019 18 quarters
Ginkgo Bioworks Holdings Inc 2.0% 198,606,619 335.6M USD +9.0% increased Q3 2021 10 quarters
Twist Bioscience Corp 1.6% 7,213,257 265.9M USD +6.3% increased Q2 2019 19 quarters
PagerDuty Inc 1.6% 11,413,423 264.2M USD +8.1% increased Q1 2020 16 quarters
Beam Therapeutics Inc 1.5% 9,393,889 255.7M USD +6.9% increased Q4 2020 13 quarters
10X Genomics Inc 1.3% 4,041,287 226.2M USD +35.0% increased Q2 2020 15 quarters
Veracyte Inc 1.2% 7,655,603 210.6M USD +0.8% increased Q4 2016 or earlier 29 quarters
Recursion Pharmaceuticals Inc 1.2% 20,654,287 203.7M USD +200.4% increased Q2 2021 11 quarters
PLTR Palantir Technologies 1.1% 10,937,859 187.8M USD +16.1% increased Q2 2023 3 quarters
TER Teradyne 1.0% 1,500,456 162.8M USD +5.5% increased Q4 2016 or earlier 29 quarters
TTD The Trade Desk 0.9% 2,149,654 154.7M USD +1,162.0% increased Q2 2023 3 quarters
ACHR Archer Aviation 0.9% 24,907,280 152.9M USD +4.7% increased Q3 2021 10 quarters
META Meta Platforms 0.6% 309,363 109.5M USD +7.8% increased Q2 2023 3 quarters
Schrodinger Inc/United States 0.6% 3,053,521 109.3M USD +7.7% increased Q2 2020 15 quarters
Verve Therapeutics Inc 0.6% 7,025,116 97.9M USD +35.1% increased Q2 2021 11 quarters
Iridium Communications Inc 0.5% 2,173,964 89.5M USD +12.9% increased Q3 2019 18 quarters
CareDx Inc 0.5% 7,194,722 86.3M USD +7.7% increased Q2 2019 19 quarters
Accolade Inc 0.5% 6,805,208 81.7M USD +12.6% increased Q3 2020 14 quarters
Arcturus Therapeutics Holdings 0.4% 2,047,687 64.6M USD +7.7% increased Q2 2019 19 quarters
Adaptive Biotechnologies Corp 0.4% 12,806,513 62.8M USD +11.3% increased Q2 2020 15 quarters
Pinterest Inc 0.3% 1,444,579 53.5M USD +152.3% increased Q1 2023 4 quarters
Adyen NV 0.3% 40,246 51.9M USD +2.6% increased Q1 2019 20 quarters
VRTX Vertex Pharmaceuticals 0.3% 124,197 50.5M USD +7.7% increased Q3 2020 14 quarters
908 Devices Inc 0.3% 4,346,579 48.8M USD +8.3% increased Q4 2020 13 quarters
AMD Advanced Micro Devices 0.3% 310,882 45.8M USD +16.7% increased Q1 2023 4 quarters
Cerus Corp 0.3% 20,914,326 45.2M USD +4.2% increased Q4 2016 or earlier 29 quarters
Global-e Online Ltd 0.3% 1,133,401 44.9M USD +7.0% increased Q1 2022 8 quarters
VEEV Veeva Systems 0.3% 226,786 43.7M USD +13.5% increased Q4 2020 13 quarters
MRNA Moderna 0.3% 437,403 43.5M USD +68.3% increased Q3 2022 6 quarters
Toast Inc 0.3% 2,345,520 42.8M USD +101.5% increased Q3 2021 10 quarters
Genius Sports Ltd 0.3% 6,914,013 42.7M USD +9.9% increased Q3 2021 10 quarters
NET Cloudflare 0.2% 440,868 36.7M USD +2.6% increased Q4 2020 13 quarters
SomaLogic Inc 0.2% 14,241,979 36.0M USD +9.7% increased Q3 2022 6 quarters
INCY Incyte 0.2% 531,625 33.4M USD +7.7% increased Q4 2016 or earlier 29 quarters
Nurix Therapeutics Inc 0.2% 3,194,999 33.0M USD +23.2% increased Q4 2021 9 quarters
Quantum-Si Inc 0.2% 15,519,322 31.2M USD +7.4% increased Q2 2021 11 quarters
Prime Medicine Inc 0.2% 3,138,270 27.8M USD +19.7% increased Q4 2022 5 quarters
TSM Taiwan Semiconductor Manufacturing (ADR) 0.2% 249,821 26.0M USD +24.3% increased Q2 2023 3 quarters
Compass Pathways Plc 0.1% 2,618,871 22.9M USD +7.6% increased Q3 2022 6 quarters
JOBY Joby Aviation 0.1% 3,404,900 22.6M USD +7.2% increased Q3 2021 10 quarters
MSFT Microsoft 0.1% 58,306 21.9M USD +14.4% increased Q4 2016 or earlier 29 quarters
Spotify Technology SA 0.1% 113,178 21.3M USD +0.2% increased Q2 2018 23 quarters
Repare Therapeutics Inc 0.1% 2,821,560 20.6M USD +7.7% increased Q4 2020 13 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Show more (up to 500) Shown: the 50 largest of 94 positions.

Breakdown by sector

  • Financials 17.1%
  • Technology 7.9%
  • Consumer Discretionary 5.7%
  • Industrials 1.6%
  • Health Care 1.3%
  • Communication Services 0.8%
  • not in our coverage 65.5%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close